Clinical Trial Update: Clinical Implementation of TNM-immunoscore in Resected Non-small Cell Lung Cancer

View source ↗

Summary

This clinical trial update discusses implementing TNM-immunoscore as a prognostic tool in patients with resected non-small cell lung cancer. The study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University Hospital of North Norway | Conditions: Non-Small Cell Lung Cancer | Status: ACTIVE_NOT_RECRUITING